Study of anal HPV in women with long-term transplants
Part of Cancer, Digestive system, Infections clinical trials.
This study looks at anal HPV (a common virus linked to some cancers) in women who have had a kidney, liver, or heart transplant for over 10 years. It aims to learn more about HPV risks so we can improve prevention and care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 75 years old.
- You have had a kidney, liver, or heart transplant for more than 10 years, or have been on immunosuppressive medicines for more than 10 years.
- You are covered by health insurance.
- You are not currently pregnant and have no history of anal cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a prevention program for anal cancer in men who have sex with men who are at higher risk, such as those with HIV or taking PrEP. It aims to find and treat early signs of anal cancer to stop it from developing.
This study looks at how human papillomavirus (HPV) and skin cancer behave in people who have had a solid organ transplant. It also includes healthy people for comparison, to understand what might be different after transplant and immune medicines.
This study looks at using a simple swab to screen for HPV (the virus that can cause anal cancer) in people living with HIV. By collecting a sample from the anal area, the study aims to find a less invasive way to check for risk, helping you avoid more uncomfortable procedures unless needed.
This study looks at HPV (the virus that can cause anal cancer) and checks if certain types of high-risk HPV are linked to abnormal cells or cancer in the anus, 10 years after joining the IPERGAY trial. It helps researchers understand long-term risks.
This study looks at follow-up care for anal (rear passage) HPV risk in adults who previously had high-risk HPV–related gynecologic changes. It aims to better track disease that may be related to HPV and possibly help guide future monitoring.
This trial checks whether tumor samples contain HPV DNA (genetic material from the HPV virus). The goal is to improve detection in anal and cervical cancers, especially in patients planning standard radiation treatment.
Hear when a new Human Papillomavirus Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.